生命银行
疾病
生物标志物
细胞外基质
高强度
生物
计算生物学
生物标志物发现
蛋白质组学
病理生理学
生物信息学
医学
神经科学
白质
病理
蛋白质组
鉴定(生物学)
脑脊液
动脉发生
仿形(计算机编程)
认知功能衰退
串扰
图谱
诊断生物标志物
认知障碍
人脑
血管疾病
信号转导
免疫学
肌肉疾病
多发性硬化
血脑屏障
作者
Inès Hristovska,Alexa Pichet Binette,Atul Kumar,Malin Wennström,Chris Gaiteri,Linda Karlsson,Olof T. Strandberg,Shorena Janelidze,Danielle van Westen,Erik Stomrud,Sebastian Palmqvist,Rik Ossenkoppele,Niklas Mattsson,Jacob W. Vogel,Oskar Hansson
出处
期刊:Nature Aging
[Nature Portfolio]
日期:2026-02-24
卷期号:6 (3): 703-721
被引量:26
标识
DOI:10.1038/s43587-026-01081-7
摘要
The pathophysiology underlying various manifestations of cerebral small-vessel disease (cSVD) remains poorly understood. Using high-throughput proteomics, we identified common and distinct proteomic signatures of white matter lesions (WMLs), microbleeds, infarcts and their subtypes, measured in 1,670 living patients. Across all cSVD manifestations, markers of extracellular matrix dysregulation and vascular remodeling were increased, including ELN, POSTN, CCN2 and especially MMP12, implicating endothelial and smooth muscle cells of the brain. These proteins were validated in cerebrospinal fluid from two additional datasets, and a subset detected in plasma predicted future cerebrovascular events in the UK Biobank better than risk scores currently used in clinical practice. Analysis focusing on WMLs found microglial-associated proteins associated with faster WML progression, whereas specific neuron-derived proteins mediated the link between WMLs and longitudinal cognitive decline. These data provide a comprehensive atlas of cSVD biomarkers, and our findings provide a promising roadmap for future diagnostics and therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI